Skip to main content

Woodline Partners LP

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1784547 San Francisco, CA

Position in AMLX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$11,756,620
+$1,544,092 QoQ
Shares Held
845,800
+0.0% QoQ
Ownership
0.761%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
15 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $139,051,923 across 13 Drug Manufacturers - Specialty & Generic names. AMLX ranks #6 (8.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 AMLX
Amylyx Pharmaceuticals, Inc.
This page
845,800 $11,756,620

All Filings in AMLX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $11,756,620 845,800
2025-12-31 $10,212,528 845,408
2025-09-30 $11,487,491 845,290
2025-06-30 $7,693,858 1,200,290
2025-03-31 $5,697,442 1,609,447
2024-06-30 $995,166 523,772
2024-03-31 $1,487,512 523,772
2023-12-31 $6,930,190 470,801
2023-09-30 $16,466,183 899,300
2023-06-30 $19,397,901 899,300
2023-03-31 $12,739,428 434,200
2022-12-31 $18,783,643 508,353
2022-09-30 $28,723,809 1,020,384
2022-06-30 $7,515,810 390,229
2022-03-31 $5,014,442 390,229